glp-1 sarcopenia in the era of receptor agonists: Implications for the internist Balancing weight and muscle loss

Additional studies are focused on how storage conditions, handling procedures, and repeated use may impact solution integrity and performance in in vitro research systems

It is well described that relatively high doses of anti-PCSK9 antibodies, as for instance 140 mg every two weeks of evolocumab, are required to overcome the antigen sink 37,38

When Chest Pain Requires Immediate Medical Evaluation Seek emergency care immediately if chest pain is accompanied by shortness of breath, dizziness, fainting, severe pressure, radiating arm pain, or sweatingthese are classic signs of acute cardiovascular events regardless of medication use

PubMed, doi:10.2165/00002512-200522060-00006

Purpose-built for physicians Phentermine may help certain patients lose more weight after discontinuing GLP-1s Key takeaways: Patients on phentermine who gained weight on a GLP-1 had a median 3% weight loss the year after GLP-1 discontinuation